Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma.
Gutiérrez-González A, Martínez-Moreno M, Samaniego R, Arellano-Sánchez N, Salinas-Muñoz L, Relloso M, Valeri A, Martínez-López J, Corbí ÁL, Hidalgo A, García-Pardo Á, Teixidó J, Sánchez-Mateos P.
Gutiérrez-González A, et al. Among authors: relloso m.
Blood. 2016 Nov 3;128(18):2241-2252. doi: 10.1182/blood-2016-01-695395. Epub 2016 Sep 13.
Blood. 2016.
PMID: 27625360
Free article.